Skip to main content
Premium Trial:

Request an Annual Quote

Intrexon Buys Agarigen, Creates AgBio Division

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic biology firm Intrexon today announced it has formed its Agricultural Biotechnology Division and acquired Agarigen for an undisclosed amount.

Matthew Crisp, formerly a managing director at investment firm Third Security, was appointed president of the AgBio Division and a senior vice president of Intrexon.

According to a spokesman for Research Triangle Park, N.C.-based Intrexon, while the AgBio Division had been planned for some time, independent of the Agarigen purchase, the deal facilitated and hastened the division's creation.

Agarigen, based in Durham, N.C., has developed a novel, mushroom-based expression platform for the rapid, high-yield production of recombinant proteins, based on technology developed by and acquired from Peter Romaine, a professor of plant pathology at Pennsylvania State University,

In a statement, Thomas Reed, CSO of Intrexon, said that the acquisition of Agarigen "underscores the close synergy" between Intrexon's core technology capabilities and the next generation of agbio expression platforms. Mushrooms are prodigious producers of complex proteins and are attractive biological systems "for the scalable and cost-effective production of specialized, high-value recombinant products," he said.

Crisp added that the creation of the AgBio division has been in the works since 2009.

"Many of the agbio advancements that have occurred over the past two decades are now ready for Intrexon's ability to tightly integrate and control multiple traits and genetic circuits to maximize yield, lower costs, and deliver the next wave of opportunities for agbio applications and products," he said.

The AgBio division will be based in Durham.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.